-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Tcr2 Therapeutics Inc. quarterly/annual General and Administrative Expense history and growth rate from Q1 2018 to Q1 2023.
- Tcr2 Therapeutics Inc. General and Administrative Expense for the quarter ending March 31, 2023 was $8.2M, a 29.8% increase year-over-year.
- Tcr2 Therapeutics Inc. General and Administrative Expense for the twelve months ending March 31, 2023 was $26.3M, a 13.7% increase year-over-year.
- Tcr2 Therapeutics Inc. annual General and Administrative Expense for 2022 was $24.4M, a 8.6% increase from 2021.
- Tcr2 Therapeutics Inc. annual General and Administrative Expense for 2021 was $22.5M, a 34.6% increase from 2020.
- Tcr2 Therapeutics Inc. annual General and Administrative Expense for 2020 was $16.7M, a 20.3% increase from 2019.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Quarterly (USD)
General and Administrative Expense, YoY Quarterly Growth (%)